Insider Transactions

Print Print page     Email Email page

Date Name Sorted Ascending Title Type Shares Traded Price Range
Mar 12, 2008 burge daniel j Officer Statement of Ownership 0 n/a
Oct 17, 2006 clark edward a Beneficial Owner (10% or more) Statement of Ownership 0 n/a
Sep 1, 2009 facet biotech corp Beneficial Owner (10% or more) Statement of Ownership 0 n/a
Oct 23, 2006 Fhm III, Llc Beneficial Owner (10% or more) Acquisition (Non Open Market) 2,155,688 n/a
Oct 18, 2006 Fhm III, Llc Beneficial Owner (10% or more) Buy 42,384 13.00
Oct 17, 2006 Fhm III, Llc Beneficial Owner (10% or more) Statement of Ownership 0 n/a
Oct 23, 2006 gillis steven Director Acquisition (Non Open Market) 2,288,486 n/a
Oct 18, 2006 gillis steven Director Buy 44,640 13.00
Oct 23, 2006 Gillis, Steven PH.d. Beneficial Owner (10% or more) Acquisition (Non Open Market) 2,288,486 n/a
Oct 17, 2006 Gillis, Steven PH.d. Beneficial Owner (10% or more) Buy 44,640 13.00
Oct 18, 2006 heron patrick Director Buy 42,384 13.00
Oct 23, 2006 heron patrick j Director Acquisition (Non Open Market) 2,155,688 n/a
Oct 23, 2006 hove anders d Director Acquisition (Non Open Market) 1,822,451 n/a
Oct 23, 2006 hove anders d Director Buy 35,181 13.00
Sep 5, 2008 mann david a Director Buy 1,600 4.27
Sep 4, 2008 mann david a Director Buy 1,400 4.20
Sep 3, 2008 mann david a Director Buy 1,000 4.15
Nov 20, 2007 mann david a Director Buy 4,000 10.00
Dec 1, 2006 mann david a Director Buy 1,935 18.35 - 18.88
Nov 29, 2006 mann david a Director Buy 3,000 18.50
Showing 1-20 of 44 transactions Page: 1 2 3  See Next 20

Stock transaction information provided by EDGAR Online. Trubion Pharmaceuticals, Inc. makes no representations or warranties with respect to the information contained herein and takes no responsibility for supplementing, updating, or correcting any such information. This listing does not include non-monetary transactions, such as stock option grants or shares purchased through the employee stock purchase plan. For recent transactions including non-monetary transactions, see our Section 16 SEC filings page.